This study was undertaken in order to assess whether triglycerides and/or their fatty acids directly influence the secretion of plasminogen activator inhibitor type 1 (PAI-1) in HepG2 cells. To this end, subconfluent HepG2 cells were incubated with triglyceride-rich particles (TGRP) isolated from Intralipid for 16 h, and PAI-1 levels were determined in conditioned medium using a specific ELISA. TGRP (1 to 6 mg triglycerides/ml) concentration-dependently increased PAI-1 secretion by cells, concomitantly with significant increases in intracellular triglyceride (TG) levels. Fatty acid analysis indicated that the incubation of cells with 3 mg of TG per ml of TGRP induced significant accumulation of 18:2 n-6 (linoleic acid, LA) and 18:3 n-3 (lin...
The release of tissue factor pathway inhibitor (TFPI) from human umbilical vein endothelial cells (H...
ids (FFA) to liver results in enhanced rates of secretion of triglycerides in lipoproteins. However,...
The fibrinolytic system is regulated by the balance between the levels of tissue-type plasminogen ac...
Impaired fibrinolytic function secondary to elevated plasma plasminogen activator inhibitor-1 (PAI-1...
In vivo studies have demonstrated a strong positive correlation between plasma very low density lipo...
Previous studies have shown that plasminogen activator inhibitor type 1 (PAI-1) levels are elevated ...
The effect of VLDL on plasminogen activator inhibitor type 1 biosynthesis in HepG2 cells was investi...
In this study the effects of very low density lipoproteins (VLDL) isolated from plasma of normal don...
AbstractTo determine whether unsaturated fatty acids induce changes in the mRNA level of plasminogen...
In normal subjects and in patients with cardiovascular disease, plasma triglycerides are positively ...
Abstract—The increased expression of plasminogen activator inhibitor type-1 (PAI-1) is associated wi...
Clinical studies have demonstrated an impaired fibrinolytic function in patients with angiographical...
We have previously shown that very low density lipoproteins (VLDL) enhance the biosynthesis of plasm...
AbstractPlasminogen activator inhibitor-1 (PAI-1) is a primary endogenous inhibitor of tissue-type p...
金沢大学大学院医学系研究科環境社会医学Plasminogen activator inhibitor 1 (PAI-1) is an important mediator of atheroscler...
The release of tissue factor pathway inhibitor (TFPI) from human umbilical vein endothelial cells (H...
ids (FFA) to liver results in enhanced rates of secretion of triglycerides in lipoproteins. However,...
The fibrinolytic system is regulated by the balance between the levels of tissue-type plasminogen ac...
Impaired fibrinolytic function secondary to elevated plasma plasminogen activator inhibitor-1 (PAI-1...
In vivo studies have demonstrated a strong positive correlation between plasma very low density lipo...
Previous studies have shown that plasminogen activator inhibitor type 1 (PAI-1) levels are elevated ...
The effect of VLDL on plasminogen activator inhibitor type 1 biosynthesis in HepG2 cells was investi...
In this study the effects of very low density lipoproteins (VLDL) isolated from plasma of normal don...
AbstractTo determine whether unsaturated fatty acids induce changes in the mRNA level of plasminogen...
In normal subjects and in patients with cardiovascular disease, plasma triglycerides are positively ...
Abstract—The increased expression of plasminogen activator inhibitor type-1 (PAI-1) is associated wi...
Clinical studies have demonstrated an impaired fibrinolytic function in patients with angiographical...
We have previously shown that very low density lipoproteins (VLDL) enhance the biosynthesis of plasm...
AbstractPlasminogen activator inhibitor-1 (PAI-1) is a primary endogenous inhibitor of tissue-type p...
金沢大学大学院医学系研究科環境社会医学Plasminogen activator inhibitor 1 (PAI-1) is an important mediator of atheroscler...
The release of tissue factor pathway inhibitor (TFPI) from human umbilical vein endothelial cells (H...
ids (FFA) to liver results in enhanced rates of secretion of triglycerides in lipoproteins. However,...
The fibrinolytic system is regulated by the balance between the levels of tissue-type plasminogen ac...